BioSpace News Archive

New Micro-Simulation Study in Cancer Medicine Finds Epi proColon® Provides Clinically Meaningful Reductions in Incidence and Mortality of Colorectal Cancer

Adherence rates and screening intervals recognized as decisive elements of successful screening strategies

November 29, 2019
·
8 min read
Pharm Country

ContraFect to Present at the Piper Jaffray 31st Annual Healthcare Conference

ContraFect Corporation announced that Roger J. Pomerantz, MD, President, Chief Executive Officer and Chairman of ContraFect, will participate in a fireside chat at the Piper Jaffray 31st Annual Healthcare Conference on Tuesday, December 3, 2019, at 12:00 PM ET in New York City.

November 29, 2019
·
4 min read
BioCapital

GlycoMimetics to Present at the Piper Jaffrey 31st Annual Healthcare Conference 2019

GlycoMimetics, Inc. announced that Chief Executive Officer Rachel King will provide a company overview at the Piper Jaffrey 31st Annual Healthcare Conference in New York, New York, which takes place on December 3, 2019.

November 29, 2019
·
1 min read
Deals

Xeris Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - November 27, 2019

Xeris Pharmaceuticals, Inc. announced that on November 27, 2019, the Compensation Committee of Xeris’ Board of Directors granted non-qualified stock options for an aggregate of 8,000 shares of its common stock to 4 new employees under Xeris’ Inducement Equity Plan.

November 29, 2019
·
2 min read
Business

FSD Pharma Reports Third Quarter 2019 Financial Results

Announces intent to initiate Phase 1 first-in-human safety and tolerability trials for its lead candidate, PP 101 micro-PEA during 1Q20

November 29, 2019
·
6 min read